Share: Facebook Twitter GooglePLus LinkedIn
Activity Provided By:

CME Outfitters

What the Future Holds for NASH: An Augmented Reality Look into Disease Stating and Targeted Therapies

Access Activity

Overview / Abstract:

Statement of Need
Given the rising prevalence of non-alcoholic fatty liver disease (NAFLD) and the societal and economic burden of its aggressive subtype, non-alcoholic steatohepatitis (NASH), it is important that hepatologists and gastroenterologists are equipped with the latest tools to diagnose NASH. While there are currently no approved therapies for the treatment of NASH, several targeted therapies are being investigated in clinical trials, with high probability of being approved in the near future. Hence, it is imperative that hepatologists and gastroenterologists have up to date knowledge regarding the latest clinical data on NASH therapies.

This CME Outfitters webcast features expert faculty integrating augmented reality (AR) to discuss pathways, therapeutic targets, and disease progression providing the learners with the best visual experience to enable them to integrate the latest tools for diagnosis and management of patients with NASH.

Learning Objectives

At the end of this CE activity, participants should be able to:
- Describe the role of immune, inflammatory, and metabolic pathways in the pathogenesis of NASH.
- Select appropriate non-invasive and invasive modalities for the identification of advanced fibrosis in patients with NAFLD.
- Evaluate the efficacy of emerging therapies for improving fibrosis in patients with NASH.

The following learning objectives pertain only to those requesting CNE or CPE credit:
- Describe the role of immune, inflammatory, and metabolic pathways in the pathogenesis of NASH.
- Determine appropriate non-invasive and invasive modalities for the identification of advanced fibrosis in patients with NAFLD.
- Evaluate the efficacy of emerging therapies for improving fibrosis in patients with NASH.

Expiration

Dec 31, 2020

Discipline(s)

Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME

Format

Online, Podcast, Webinar / Webcast / Video

Credits / Hours

1.5 AMA PRA Category 1 Credit(s)TM

Accreditation

ACCME

Presenters / Authors / Faculty

Zobair M. Younossi, MD, MPH, FACP, FACG, AGAF, FAASLD
Chairman, Department of Medicine
Professor Medicine
Inova Fairfax Hospital
Fairfax, VA

Rohit Loomba, MD, MHSc
Director, NAFLD Research Center Director of Hepatology Professor of Medicine
Vice Chief, Division of Gastroenterology
University of California, San Diego
San Diego, CA

Mazen Noureddin, MD, MHSc
Director, Fatty Liver Program
Division of Digestive & Liver Diseases
Comprehensive Transplant Center
Cedars Sinai Medical Center
Los Angeles, CA

Activity Specialities / Related Topics

Primary Care, Internal Medicine, Gastroenterology / GI

Sponsors / Supporters / Grant Providers

Intercept Pharmaceuticals

Keywords / Search Terms

CME Outfitters, LLC NASH, NAFLD, fatty liver, hepatology, gastroenterology, internal medicine, liver disease, liver Free CE CME

Access Activity

RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.